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Abstract
Background: PRISMA guidelines have been developed to improve the reporting of systematic reviews (SRs). Other reporting
guidelines and techniques to assess methodological quality of SRs have been developed. We aimed to assess the frequency
of the use of reporting and other guidelines in SRs to assess whether PRISMA is being used inappropriately as a substitute
for other relevant guidelines.
Methods: Web of Knowledge was searched to identify articles citing the PRISMA guidelines over a 12-month period. The
use of reporting guidelines (including PRISMA and MOOSE) and tools for assessing methodological quality (including
QUADAS) was assessed. Factors associated with appropriate use of guidelines including review type, field of publication and
involvement of a methodologist were investigated.
Results: Over the 12-month period, 701 SRs were identified. MOOSE guidelines were cited in just 17% of epidemiologic
reviews; QUADAS or QUADAS-2 was referred to in just 40% of diagnostic SRs. In the multivariable analysis, medical field of
publication and methodologist involvement (OR= 1.97, 95% CI: 1.37, 2.83) were significant predictors of appropriate use of
guidelines. Inclusion of a meta-analysis resulted in 73% higher odds of appropriate usage of systematic review guidelines
(OR= 1.73, 95% CI: 1.22, 2.35).
Conclusions: Usage of SR reporting guidelines and tools for assessment of methodological quality other than PRISMA may
be under-utilized with negative implications both for the reporting and methodological quality of systematic reviews.
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Introduction
Systematic reviews (SRs) are ‘‘prepared using a systematic
approach to minimizing biases and random errors which is
documented in a materials and methods section’’ [1] and have
become established as a linchpin of evidence-based practice,
influencing clinical practice and informing health policy. It is,
therefore, important that SRs adhere to rigorous methodology and
are clear and unbiased. While interventional SRs are prominent in
the assessment of the comparative effectiveness of healthcare
procedures, other reviews including epidemiologic reviews, reviews
of diagnostic tests, qualitative reviews and individual patient meta-
analysis are commonplace and increasingly influential [2]. There
is, therefore, a similar onus on clear and accurate reporting of
these types of SR.
A plethora of reporting and methodological guidelines have
been developed to assist in the reporting and conduct of all aspects
of research, including SRs [3] and randomized controlled trials
(CONSORT [4] and its extensions) and observational studies (e.g.
STROBE [5]). These guidelines have had a positive impact on the
reporting of research, although further work and awareness is
required to elevate the standard of reporting to required levels [6–
8]. Appropriate reporting of meta-analyses was initially outlined in
the QUOROM statement [9]. This was subsequently updated to
encompass systematic reviews generally. However, guidelines and
adjuncts tailored specifically to each type of systematic review
exist. For example, MOOSE guidelines [10] guide the reporting
and conduct of epidemiologic reviews, AMSTAR is accepted as a
valid tool for assessing the methodological quality of interventional
SRs [11], while QUADAS [12] and latterly QUADAS-2 [13]
have been developed to aid methodological assessment in
diagnostic reviews.
Inadequate reporting risks shrouding the conduct of systematic
reviews impairing potential judgements in relation to the emphasis
that should be placed upon their results and conclusions. It is,
therefore, important that these guidelines are considered and
applied where necessary to optimise both the conduct and
reporting of all types of SR. The aims of the present research
were to assess the frequency of correct use of appropriate
guidelines in SRs and to highlight factors associated with
inappropriate use or omission of relevant guidelines.
Methods
Articles citing the PRISMA guidelines were searched from
January 1st to December 31st 2012, using the Web of Knowledge
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database (http://apps.webofknowledge.com) by one of the authors
(PSF). The first step consisted of a search for PRISMA
publications on the PRISMA website (http://prisma-statement.
org). The ‘Create citation report’ tool on the Web of Knowledge
database was accessed to identify articles citing one of these six
PRISMA guideline articles. SRs only were to be included in the
research with other article types including narrative reviews, meta-
epidemiologic studies, letters, editorials and other studies excluded
from the analysis.
Two researchers (PSF and DK) screened the titles and abstracts
of all retrieved references. Electronic versions of potentially eligible
reviews were retrieved and analyzed by the authors to assess
eligibility. Review articles without a specific methodology section
were excluded. Two reviewers independently extracted data from
eligible reviews using piloted forms. Calibration was initially
undertaken on 10 articles and disagreements were resolved
through consensus or by discussion with a third reviewer (NP).
Data were obtained on the type of systematic review, medical
field of publication, number of authors, involvement of a
methodologist or statistician in the paper, specific PRISMA article
cited, reason for the citation, and whether meta-analysis was
undertaken. The involvement of a methodologist was gauged from
affiliations or qualifications reported and information in the review
methodology section.
Descriptive statistics were performed to categorize the number
of SRs identified within each medical field and to relate reporting
to the remaining study characteristics. Pearson chi-squared test
and Fisher’s exact test were used to determine the association
between appropriate PRISMA citation and trial characteristics
including medical specialty, number of authors, methodologist
involvement, specific PRISMA statement article cited, reason for
citation, type of SR, and implementation of meta-analysis or
otherwise. Univariable and multivariable logistic regression
modeling was used to determine the association between
appropriate PRISMA statement citation and predictor variables
including medical field of research, number of authors, method-
ologist involvement, cited article and whether meta-analysis was
undertaken. The adequacy of the model was assessed using the
Hosmer-Lemeshow test. The level of statistical significance for all
tests was pre-specified at 0.05. All statistical analyses were
conducted with statistical software (Stata 12.1, Stata Corp, College
Station, TX, USA).
Results
Seven hundred and one SRs were identified pertaining to 10
medical fields (Figure 1, Table 1). The highest number of SRs was
published in General Medical (n = 121), Public Health (n = 103)
and Cardiovascular (n = 93) fields. The majority of studies were
authored by more than 6 researchers without the involvement of a
methodologist and included meta-analysis. Most were interven-
tional SRs, citing PRISMA as a guideline for reporting reasons,
while the most frequently cited article was that of Moher et al.,
(2009) published in PLoS Medicine. The guideline most frequently
omitted within the subset of SRs citing only PRISMA [3] was
MOOSE [9] (Table 2), with 236/284 (83%) of epidemiologic
reviews citing the latter guidelines, in isolation. Similarly, in SRs of
diagnostic tests 23/57 (40%) cited PRISMA without referring to
either QUADAS or QUADAS-2, the remainder cited PRISMA3
in isolation.
In the univariable analysis (Table 3), medical field of research
was associated with appropriate PRISMA [3] citation (Other:
OR=2.23, 95% CI: 1.25, 4.0; Obstetrics: OR=2.87, 95% CI:
1.36, 6.05; General Medicine: OR=3.17, 95% CI: 1.82, 5.50;
General Surgery: OR=4.02, 95% CI: 1.78, 9.09; Cardiovascular:
OR=5.22, 95% CI: 2.76, 9.88; Orthopedics/Physiotherapy:
OR=3.75, 95% CI: 1.65, 8.53; Dentistry: OR=3.80, 95% CI:
1.38, 10.42; compared to Public Health). Involvement of a
methodologist and use of meta-analysis were also identified as
significant predictors for the outcome. In the multivariable analysis
(Table 3), medical field (Other: OR=2.57, 95% CI: 1.41, 4.69;
Obstetrics: 3.40, 95% CI: 1.58, 7.33; General Medicine:
OR=3.41, 95% CI: 1.93, 6.04; General Surgery: OR=4.91,
95% CI: 2.12, 11.37; Cardiovascular: OR=5.11, 95% CI: 2.63,
9.91; Orthopedics/Physiotherapy: OR=5.40, 95% CI: 2.30,
12.64; Dentistry: OR=5.68; 95% CI: 2.01, 16.02; compared to
Public Health) and methodologist involvement (OR=1.97, 95%
CI: 1.37, 2.83; compared to non-involvement) remained signifi-
cant predictors of appropriate PRISMA citation. There was also
evidence that inclusion of a meta-analysis was associated with
Figure 1. Flow diagram of article retrieval.
doi:10.1371/journal.pone.0096407.g001
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appropriate citation of SR guidelines (OR=1.73, 95% CI: 1.22,
2.35). The predicted probabilities from the adjusted model for
appropriate PRISMA citation are shown by medical field and
inclusion of a meta-analysis or otherwise in Figure 2.
Discussion
The requirement for high quality systematic reviews of
healthcare interventions, epidemiological data and diagnostic
information is clear as the emphasis on evidence-based decision-
making continues. A corollary of this situation is for more
complete and transparent reporting of the design and conduct of a
SR, allowing stakeholders to reach informed decisions based on
the validity of the findings. The PRISMA guidelines [3] were
developed with the expressed aim of standardizing reporting and
enhancing the clarity of reporting of SRs. While the emphasis of
the guidelines changed from a focus on interventional research to a
more generic approach from its precursor [9], the PRISMA [3]
guidelines do not consider nuances of certain aspects of other
review types. It is, therefore, important that its use is supplemented
by reference to additional tailored reporting and quality assess-
ment guidelines in respect of these review types. The findings from
the present study, however, indicate that a significant percentage
of epidemiologic and diagnostic reviews are published without
reference to these complementary resources.
While there is significant overlap between MOOSE [10] and
PRISMA [3], there are items unique to each with MOOSE [10]
guidelines comprised of 35 items. In particular, MOOSE [10]
incorporates very detailed instructions in respect of search strategy,
including delineation of the qualifications of the searchers, use of
hand-searching and approaches to dealing with unpublished and
non-English literature, emphasizing the centrality of this aspect of
the review to meta-analysis. The importance of the assessment of
the potential for bias in primary studies is reinforced in both
guidelines. However, greater emphasis is placed on the interpre-
tation of the results of the review, specifically regarding possible
alternate explanations for the observed findings in the MOOSE
guidelines [10]. This distinction reflects the elevated susceptibility
of observational research to both bias and confounding limiting
the potential inferences and the degree to which the results of the
review can be trusted and used to inform healthcare decisions [14].
The finding from the present study of 83% of epidemiologic
reviews citing PRISMA [3] without referring to MOOSE [10]
suggests that these reviews may lack complete reporting of these
methodological aspects and failure to explore the reasons for the
observed findings in sufficient detail.
Meta-analyses of diagnostic tests have become increasingly
prominent in medicine and will potentially have an increasing role
in healthcare as decision makers consult the evidence before
implementing new diagnostic technologies. It is important that
such analyses provide reliable results; this is contingent upon both
the quality of conduct and the clarity of reporting. As with over
review types, diagnostic systematic reviews are susceptible to
shortcomings pertaining to conduct and reporting [15–17]. To
mitigate potential weaknesses, quality assessment of the primary
studies has become integral to diagnostic reviews; the QUADAS
[12] and more recently QUADAS-2 [13] guidelines have
facilitated this process. The present study, however, revealed that
40% of diagnostic reviews did not refer to either of these guidelines
risking inadequate methodological comparison of constituent
primary studies in diagnostic reviews.
Disentanglement of the conduct of SRs from reporting is more
complex than is the case with primary studies, as significant
overlap exists between the two. Nevertheless, PRISMA guidelines
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[3] were developed with the intention of improving the reporting
of reviews; the AMSTAR guidelines [11] have emerged as a valid
tool to assess the conduct of SRs. While meta-epidemiologic
studies were omitted from the analysis in the present cross-
sectional study, it was noted that 14% of these also failed to refer to
AMSTAR guidelines [11] during methodological assessment of
SRs suggesting an over-reliance on PRISMA [3] in this further
respect. It is, therefore, important that greater awareness of these
guidelines arises.
The over-reliance on PRISMA guidelines [3] in respect of
reporting of SRs reflects widespread awareness and endorsement
of these guidelines. This is certainly a positive development, which
has led to enhanced reporting of SRs [6], although further work is
required [7,8]. However, while a plethora of reporting guidelines
are available in a prominent on-line resource [18], lack of
awareness of alternatives and complementary guidelines is
potentially problematic. This situation may relate to widespread
espousal and endorsement of reporting guidelines including
PRISMA [3] and CONSORT [4] by biomedical journals, while
Table 2. Omitted guideline among the subset of SRs citing PRISMA, based on field of publication (n = 263).
Medical Field Omitted guideline Total
MOOSE QUADAS/QUADAS-2 AMSTAR
N (%) N (%) N (%) N (%)
Public Health 55 (23) 4 (17) 0 (0) 59 (22)
Psychiatry/Neurology 32 (14) 2 (9) 1 (25) 35 (13)
Oncology 38 (16) 2 (9) 1 (25) 41 (16)
Other 29 (12) 4 (17) 0 (0) 33 (13)
Obstetrics 11 (5) 1 (4) 2 (50) 14 (5)
General Medicine 33 (14) 3 (13) 0 (0) 36 (14)
General Surgery 9 (4) 1 (4) 0 (0) 10 (4)
Cardiovascular 18 (7) 1 (4) 0 (0) 19 (7)
Orthopedics/Physiotherapy 7 (3) 3 (13) 0 (0) 10 (4)
Dentistry 4 (2) 2 (9) 0 (0) 6 (2)
Total 236 (100) 23 (100) 4 (100) 263 (100)
doi:10.1371/journal.pone.0096407.t002
Figure 2. Predicted probabilities of appropriate PRISMA citation with 95% confidence intervals (CIs) derived from the adjusted
model based on the medical field and implementation of a meta-analysis within the SR.
doi:10.1371/journal.pone.0096407.g002
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other guidelines, including MOOSE [10] and QUADAS [12],
have not been treated similarly. In recent times efforts have been
made to improve compliance with PRISMA guidelines using
active editorial involvement [6]; these efforts have not been
replicated in respect of other guidelines, including those pertaining
to observational research. It is likely, therefore, that over-reliance
on PRISMA will continue, unless similar efforts are made to
improve awareness of complementary guidelines. It is, therefore,
important that emphasis on the reporting of not just interventional
reviews but also epidemiologic, diagnostic and other systematic
reviews is enhanced. This development will be facilitated by
raising awareness of other guidelines, such as MOOSE [10] and
QUADAS-2 [13] and encouraging active editorial input to
enhance reporting of all review types.
Potential limitations of this study included the relatively short
time period assessed; however, a large number of eligible studies
from diverse areas of medicine were included. Nevertheless,
temporal changes in reporting characteristics will not be identified.
In addition, given that the focus of the research was to assess the
usage of PRISMA guidelines specifically, it is likely that
epidemiologic and diagnostic reviews that cite more specific
guidelines in isolation, without referring to PRISMA, exist.
Conclusions
There is evidence that significant awareness of PRISMA
guidelines exist. However, usage of other accepted reporting
guidelines and tools for assessment of methodological quality have
less prominence and may be under-utilized with negative
connotations on both reporting and methodological quality of
systematic reviews.
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